Early-phase development is poised to see a big impact from the globalization of clinical research. Operating in different regions, though, can introduce a variety of complexities such as data access considerations, cultural dynamics, and regulatory differences that require careful management. Choosing the right partner to leverage global capabilities is essential. This playbook explores how established global CROs play a critical role in helping sponsors navigate global complexities in early-phase programs. An optimized region-selection strategy can unlock new opportunities. Highlights include: The unique advantages of China, Australia, and the Asia Pacific region as strategic markets for early-phase development. How Central and Eastern Europe offer a competitive environment for a scalable, cost‑efficient component of a diversified early‑phase footprint. The range of interrelated factors to consider, including nuances that drive the need for informed partners.
